Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4634251000168116 | Glycoprep-O Kit (bisacodyl 5 mg) enteric tablet [3 tablets] (&) (citric acid 14.3 g + magnesium carbonate hydrate 7.2 g) powder for oral liquid [1 x 21.5 g sachet] (&) (macrogol-3350 52.9 g + potassium chloride 740 mg + sodium chloride 2.6 g + sodium sulfate 5.6 g) powder for oral liquid [3 x 70 g sachets], 1 pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4634261000168119 | Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | Is a | Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | true | Inferred relationship | Some | ||
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | has container type | pack | true | Inferred relationship | Some | ||
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | has component pack | Glycoprep Orange powder for oral liquid, 3 x 70 g sachets | true | Inferred relationship | Some | ||
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | has component pack | Magnesium Citrate 7.2/14.3 (Fresenius Kabi) powder for oral liquid, 21.5 g sachet | true | Inferred relationship | Some | ||
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | has component pack | Bisacodyl (Fresenius Kabi) 5 mg enteric tablet, 3, blister pack | true | Inferred relationship | Some | ||
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | has TP | Glycoprep-O Kit | true | Inferred relationship | Some | ||
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | has TPUU | Bisacodyl (Fresenius Kabi) 5 mg enteric tablet | true | Inferred relationship | Some | 1979179967 | |
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | has TPUU | Glycoprep Orange powder for oral liquid, 70 g sachet | true | Inferred relationship | Some | 247781508 | |
| Glycoprep-O Kit (3 x Glycoprep Orange sachets, 3 x Bisacodyl (Fresenius Kabi) tablets, 1 x Magnesium Citrate 7.2/14.3 (Fresenius Kabi) sachet), 1 pack | has TPUU | Magnesium Citrate 7.2/14.3 (Fresenius Kabi) powder for oral liquid, 21.5 g sachet | true | Inferred relationship | Some | 661335493 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR